Developing Prediction Models for Clinical Use Using Logistic Regression: an Overview

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2019 Apr 30

PMID 31032076

Citations 118

Authors

Maren E Shipe

Stephen A Deppen

Farhood Farjah

Eric L Grogan

Affiliations

Soon will be listed here.

Abstract

Prediction models help healthcare professionals and patients make clinical decisions. The goal of an accurate prediction model is to provide patient risk stratification to support tailored clinical decision-making with the hope of improving patient outcomes and quality of care. Clinical prediction models use variables selected because they are thought to be associated (either negatively or positively) with the outcome of interest. Building a model requires data that are computer-interpretable and reliably recorded within the time frame of interest for the prediction. Such models are generally defined as either diagnostic, likelihood of disease or disease group classification, or prognostic, likelihood of response or risk of recurrence. We describe a set of guidelines and heuristics for clinicians to use to develop a logistic regression-based prediction model for binary outcomes that is intended to augment clinical decision-making.

Citing Articles

Comparison of ROX index with modified indices incorporating heart rate, flow rate, and PaO/FiO ratio for early prediction of outcomes among patients initiated on post-extubation high-flow nasal cannula therapy.

Gutta S, Ong W, Sajeed S, Chern B, Gulati Kansal M, Khan F Eur J Med Res. 2025; 30(1):166.

PMID: 40083017 PMC: 11907874. DOI: 10.1186/s40001-025-02402-z.

Predicting total healthcare demand using machine learning: separate and combined analysis of predisposing, enabling, and need factors.

Orhan F, Kurutkan M BMC Health Serv Res. 2025; 25(1):366.

PMID: 40075408 PMC: 11900254. DOI: 10.1186/s12913-025-12502-5.

Comparing conventional and Bayesian workflows for clinical outcome prediction modelling with an exemplar cohort study of severe COVID-19 infection incorporating clinical biomarker test results.

Sullivan B, Barker E, MacGregor L, Gorman L, Williams P, Bhamber R BMC Med Inform Decis Mak. 2025; 25(1):123.

PMID: 40065374 PMC: 11892292. DOI: 10.1186/s12911-025-02955-3.

Developing A Model to Predict Major Bleeding Among Hospitalized Patients Undergoing Therapeutic Plasma Exchange.

Soares Ferreira Junior A, Lessa M, Sanborn K, Gordee A, Kuchibhatla M, Karafin M J Clin Apher. 2025; 40(2):e70013.

PMID: 40045567 PMC: 11893082. DOI: 10.1002/jca.70013.

Predictive performance of risk prediction models for lung cancer incidence in Western and Asian countries: a systematic review and meta-analysis.

Juang Y, Ang L, Seow W Sci Rep. 2025; 15(1):4259.

PMID: 40038330 PMC: 11880538. DOI: 10.1038/s41598-024-83875-6.

References

Schafer J . Multiple imputation: a primer. Stat Methods Med Res. 1999; 8(1):3-15. DOI: 10.1177/096228029900800102. View

Pepe M, Janes H, Longton G, Leisenring W, Newcomb P . Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004; 159(9):882-90. DOI: 10.1093/aje/kwh101. View

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R . Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004; 8(36):iii-iv, ix-xi, 1-158. DOI: 10.3310/hta8360. View

Donders A, van der Heijden G, Stijnen T, Moons K . Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006; 59(10):1087-91. DOI: 10.1016/j.jclinepi.2006.01.014. View

Vittinghoff E, McCulloch C . Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2006; 165(6):710-8. DOI: 10.1093/aje/kwk052. View

Cassidy A, Myles J, van Tongeren M, Page R, Liloglou T, Duffy S . The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer. 2007; 98(2):270-6. PMC: 2361453. DOI: 10.1038/sj.bjc.6604158. View

Toll D, Janssen K, Vergouwe Y, Moons K . Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2009; 61(11):1085-94. DOI: 10.1016/j.jclinepi.2008.04.008. View

Steyerberg E, Vickers A, Cook N, Gerds T, Gonen M, Obuchowski N . Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2009; 21(1):128-38. PMC: 3575184. DOI: 10.1097/EDE.0b013e3181c30fb2. View

Rubin D, Schenker N . Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991; 10(4):585-98. DOI: 10.1002/sim.4780100410. View

10.

Isbell J, Deppen S, Putnam Jr J, Nesbitt J, Lambright E, Dawes A . Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg. 2010; 91(1):227-33. PMC: 3748597. DOI: 10.1016/j.athoracsur.2010.08.054. View

11.

Moons K, Kengne A, Woodward M, Royston P, Vergouwe Y, Altman D . Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012; 98(9):683-90. DOI: 10.1136/heartjnl-2011-301246. View

12.

Moons K, Kengne A, Grobbee D, Royston P, Vergouwe Y, Altman D . Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012; 98(9):691-8. DOI: 10.1136/heartjnl-2011-301247. View

13.

Hendriksen J, Geersing G, Moons K, de Groot J . Diagnostic and prognostic prediction models. J Thromb Haemost. 2013; 11 Suppl 1:129-41. DOI: 10.1111/jth.12262. View

14.

Farjah F, Lou F, Sima C, Rusch V, Rizk N . A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. J Thorac Oncol. 2013; 8(9):1170-80. DOI: 10.1097/JTO.0b013e3182992421. View

15.

McWilliams A, Tammemagi M, Mayo J, Roberts H, Liu G, Soghrati K . Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013; 369(10):910-9. PMC: 3951177. DOI: 10.1056/NEJMoa1214726. View

16.

Bilimoria K, Liu Y, Paruch J, Zhou L, Kmiecik T, Ko C . Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013; 217(5):833-42.e1-3. PMC: 3805776. DOI: 10.1016/j.jamcollsurg.2013.07.385. View

17.

Pepe M, Janes H, Li C . Net risk reclassification p values: valid or misleading?. J Natl Cancer Inst. 2014; 106(4):dju041. PMC: 3982889. DOI: 10.1093/jnci/dju041. View

18.

Deppen S, Blume J, Aldrich M, Fletcher S, Massion P, Walker R . Predicting lung cancer prior to surgical resection in patients with lung nodules. J Thorac Oncol. 2014; 9(10):1477-84. PMC: 4272613. DOI: 10.1097/JTO.0000000000000287. View

19.

Pepe M, Fan J, Feng Z, Gerds T, Hilden J . The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets. Stat Biosci. 2015; 7(2):282-295. PMC: 4615606. DOI: 10.1007/s12561-014-9118-0. View

20.

Richter A, Khoshgoftaar T . A review of statistical and machine learning methods for modeling cancer risk using structured clinical data. Artif Intell Med. 2018; 90:1-14. DOI: 10.1016/j.artmed.2018.06.002. View